Saint Paul, MN, United States of America

Stephen J Chudzik

This inventor holds 36 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Biodegradable Polymers. Top assignees: Surmodics, Inc., Bsi Corporation. Active years: 1998-2015.

USPTO Granted Patents = 36 

% Patents Active = 61.1

 

 

Average Co-Inventor Count = 2.8

ph-index = 21

Forward Citations = 2,010(Granted Patents)


Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biocompatible Foam
Glycerol Ester
Hydrophobic Polysaccharides
Drug Delivery Implants
Hydrogel Joint Repair
Bioactive Agent Release
Crosslinkable Macromers
Natural Polysaccharides
Coatings for Medical Articles
Encapsulated Cells
Macromer Composition
Immunoassay Device
36 patents (USPTO):Explore Patents

Title: Stephen J Chudzik: Innovator and Patent Holder at Surmodics, Inc.

Introduction:

In the world of biocompatible foams and active agent delivery systems, one name stands out - Stephen J Chudzik. With 31 patents to his name, Chudzik has made significant contributions to the field of medical devices and treatments. Currently working at Surmodics, Inc., Chudzik's expertise has helped pave the way for innovative advancements in healthcare.

Biocompatible Foam Patent:

Chudzik's latest patent, titled "System for forming a biocompatible foam using polymerizable alpha(1-4)glucopyranose polymers and gas-producing component," showcases his ingenuity in creating biocompatible foams with exceptional physical and chemical properties. These foams can be applied in situ or as pre-formed foam to aid in tissue treatment. Chudzik's invention utilizes a poly-α(1→4)glucopyranose macromer to form biocompatible degradable foams as well as a poly(alkylene oxide) macromer to develop biostable foams.

Active Agent Delivery System Patent:

Another notable patent held by Stephen J Chudzik is the "Glycerol ester active agent delivery systems and methods." This invention focuses on the use of glycerol esters for active agent delivery. The patent describes an active agent eluting device that includes a glycerol ester, with the active agent being dispersed within it. The device is designed to release the active agent as the glycerol ester degrades. This innovative approach paves the way for more efficient and controlled drug delivery systems.

Surmodics, Inc.:

Stephen J Chudzik's exceptional research and development skills are put to use at Surmodics, Inc. Located in St. Paul, Minnesota, Surmodics is a leading medical technology company that focuses on providing innovative solutions to enhance drug delivery, improve diagnostic devices, and develop surface modification technologies. With Chudzik's contributions, Surmodics remains at the forefront of medical advancements, shaping the future of the healthcare industry.

Collaboration with Coworkers:

Within Surmodics, Chudzik has had the opportunity to collaborate with esteemed colleagues such as Dale G Swan and Ralph A Chappa. Their combined expertise and dedication to pushing boundaries have likely played a significant role in the success of their shared projects. Collaborations such as these foster an environment of innovation, enabling inventors like Chudzik to develop groundbreaking solutions.

Conclusion:

Stephen J Chudzik's body of work and extensive patent portfolio make him a distinguished innovator in the field of biocompatible foams and active agent delivery systems. Through his contributions at Surmodics, Inc., Chudzik continues to drive forward advancements that have the potential to revolutionize medical treatments. His work highlights the importance of pushing the boundaries of medical technology and underscores the impact that patents and inventions can have on shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…